急性髓系白血病的中西医药物治疗研究进展  

Progress in the Treatment of Acute Myeloid Leukemia with Traditional Chinese and Western Medicine

作　　者：高墨含 马家乐 李军[1,2] GAO Mohan;MA Jiale;LI Jun(School of Chinese Materia Medica,Beijing University of Chinese Medicine,Beijing 100029,China;Modern Research Center for Traditional Chinese Medicine,Beijing Institute of Chinese Medicine,Beijing University of Chinese Medicine,Beijing 100029,China)

机构地区：[1]北京中医药大学中药学院,北京100029 [2]北京中医药大学北京中医药研究院中药现代研究中心,北京100029

出　　处：《中国医院用药评价与分析》2025年第1期121-124,128,共5页Evaluation and Analysis of Drug-use in Hospitals of China

基　　金：国家中医药管理局青年岐黄学者支持项目(No.国中医药人教函〔2022〕256号)。

摘　　要：急性髓系白血病是当前发病率最高的白血病类型之一,且预后不良。目前,中西医治疗急性髓系白血病均取得了一定进展,但仍存在疗效不佳、不良反应大、并发症严重等缺陷。该文梳理中西医常用的治法及药物作用机制,分析二者治疗原理上的相似之处,通过案例探讨,总结归纳中西医结合治疗急性髓系白血病的优势,展望未来发展路径,为探索新疗法、研制新药物提供参考。Acute myeloid leukemia is currently one of the types of leukemia with the highest incidence and a poor prognosis.At present,both Chinese and Western medicine have made some progress in the treatment of acute myeloid leukaemia,but there are still shortcomings such as poor efficacy,large adverse reactions and serious complications.This article reviews the commonly used treatment methods and drug action mechanisms of traditional Chinese and Western medicine,analyzes the similarities in the treatment principles,and summarizes the advantages of integrated Chinese and Western medicine in the treatment of acute myeloid leukemia through case study,and looks forward to the future development path,so as to provide references for exploring new therapies and developing new drugs.

关 键 词：急性髓系白血病 西药治疗 中药治疗 中西医结合治疗 

分 类 号：R973[医药卫生—药品] R932[医药卫生—药学]